Elicio Therapeutics, Inc. Accrued Liabilities, Current
Elicio Therapeutics, Inc. (ELTX) had Accrued Liabilities, Current of $7.29 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Accrued Liabilities, Current $7.29M.
- 2026-03-31: Accrued Liabilities, Current $5.92M.
- 2025-12-31: Accrued Liabilities, Current $6.43M.
- 2025-09-30: Accrued Liabilities, Current $5.21M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $7.29M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $5.92M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $6.43M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $5.21M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $5.11M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $5.77M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $8.41M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $4.85M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $5.32M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $3.32M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $3.76M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $4.42M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $2.31M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $1.10M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $1.94M 10-K · filed 2024-03-29 | $2.57M 10-K · filed 2023-03-17 |
| 2022-09-30 | $4.91M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $4.09M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $5.24M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $3.22M 10-K · filed 2023-03-17 | |
| 2021-09-30 | $5.35M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $4.67M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $4.09M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $6.67M 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |